Recommendation
- https://www.mayoclinic.org/diseases-conditions/psoriasis/diagnosis-treatment/drc-20355845Psoriasis - Diagnosis and treatment - Mayo ClinicMay 17, 2024 ... Psoriasis treatments aim to stop skin cells from growing so quickly and to remove scales. Options include creams and ointments (topical therapy), light therapy ...
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4894517/PubMed Central (PMC)More Biologic Therapies Expected To Treat Advanced Plaque ...Established biologic treatments for adults with moderate-to-severe plaque psoriasis include adalimumab (Humira, AbbVie); etanercept (Enbrel, Amgen); infliximab ...
- https://www.nejm.org/doi/full/10.1056/NEJMoa2102383The New England Journal of MedicineBimekizumab versus Secukinumab in Plaque Psoriasis | New ...Apr 23, 2021 ... Treatment with bimekizumab resulted in greater skin clearance than treatment with secukinumab over 16 and 48 weeks but was associated with oral candidiasis.
- https://www.webmd.com/skin-problems-and-treatments/psoriasis/researchWebMDThe Best New Medications & Treatments for PsoriasisJan 10, 2023 ... Deucravacitinib (Sotyktu) is a medication approved to treat moderate-to-severe plaque psoriasis. A first-in-class, oral, selective, allosteric ...
- https://www.nejm.org/doi/full/10.1056/NEJMoa1512711The New England Journal of MedicinePhase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisJun 8, 2016 ... Advances in understanding the pathogenic cytokine network of psoriasis have led to the development of new treatments that provide greater ...
- https://www.psoriasis.org/advance/fda-approves-sotyktu-for-psoriasis/FDA Approves Sotyktu™ for PsoriasisSep 13, 2022 ... A new oral treatment option for adults with plaque psoriasis. ... "Deucravacitinib is a once-daily oral medication with its clinical trials in ...
- https://my.clevelandclinic.org/health/diseases/22842-plaque-psoriasisCleveland ClinicPlaque Psoriasis: What It Looks Like, Causes & TreatmentPlaque psoriasis is an autoimmune condition. It causes thick patches (plaques) on your skin, including your scalp. There isn't a cure, but treatments can ...
- https://news.bms.com/news/details/2022/New-Two-Year-Deucravacitinib-Data-Reinforce-Durable-Efficacy-and-Consistent-Safety-Profile-in-Treatment-of-Moderate-to-Severe-Plaque-Psoriasis/default.aspxNew Two-Year Deucravacitinib Data ... - Bristol Myers SquibbMay 12, 2022 ... Results add to the growing body of evidence on deucravacitinib, a potential new oral treatment option for moderate to severe plaque psoriasis.
- https://pubmed.ncbi.nlm.nih.gov/32427307/PubMedPathophysiology, Clinical Presentation, and Treatment of Psoriasis ...May 19, 2020 ... ... advanced small molecule ... The most commonly prescribed light therapy used to treat plaque psoriasis is narrowband UV-B phototherapy.
- http://www.nejm.org/doi/10.1056/NEJMoa2308713The New England Journal of MedicineAn Oral Interleukin-23–Receptor Antagonist Peptide for Plaque ...Feb 8, 2024 ... The use of monoclonal antibodies has changed the treatment of several immune-mediated inflammatory diseases, including psoriasis.
Recommend
All Categories
Others
Privacy Policy
Terms of Use
We scour the internet for answers to just about everything - from finding the latest kitchenware to finding
the best travel destinations.
A unique Q&A structure provides you with relevant information in a quick-read, easy-to-use format. With the
most common questions answered in this format, you're sure to find what you're looking for.
Copyright © 2025 Seahia. All rights reserved